Across TCGA pan-cancer cohorts, IGSF11-AS1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of IGSF11-AS1’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where IGSF11-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types IGSF11-AS1 is over-expressed in tumor.
LUSC, HNSC, and UCEC are the cancer types where IGSF11-AS1 tumor–normal differential expression is most reproducible.